Mastitis and the risk of breast cancer

Epidemiology

Volumn 20, Issue 5, 2009, Pages 747-751

  Lambe, Mats ^a,b   Johansson, Anna L V ^a   Altman, Daniel ^a   Eloranta, Sandra ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Regional Oncologic Center   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MASTITIS; PRIORITY JOURNAL;

ADULT; BREAST NEOPLASMS; FEMALE; HUMANS; MASTITIS; MIDDLE AGED; POISSON DISTRIBUTION; REGISTRIES; RISK ASSESSMENT; SWEDEN; YOUNG ADULT;

EID: 69549126868     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/EDE.0b013e3181adbb1e     Document Type: Article

References (21)

1. Mantovani A, Romero P, Palucka AK, Marincola FM. Tumour immunity: effector response to tumour and role of the microenvironment. Lancet. 2008;371:771-783.
2. Ames BN, Gold LS, Willett WC. The causes and prevention of cancer. Proc Natl Acad Sci U S A. 1995;92:5258-5265.
3. Hussain SP, Harris CC. Inflammation and cancer: an ancient link with novel potentials. Int J Cancer. 2007;121:2373-2380. (Pubitemid 350022405)
4. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357:539-545. (Pubitemid 32173595)
5. Harris RE, Chlebowski RT, Jackson RD, et al. Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative. Cancer Res. 2003;63:6096-6101.
6. Steele VE, Moon RC, Lubet RA, et al. Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: methods and results from the NCI Chemoprevention Drug Development Program. J Cell Biochem. 1994;20:32-54.
7. Kinlay JR, O'Connell DL, Kinlay S. Incidence of mastitis in breastfeeding women during the six months after delivery: a prospective cohort study. Med J Aust. 1998;169:310-312. (Pubitemid 28486749)
8. WHO. Mastitis: Cures and Management. Geneva, Switzerland: The World Health Organization; 2000. FCU, CAU/1000.
9. Kinlay JR, O'Connell DL, Kinlay S. Risk factors for mastitis in breastfeeding women: results of a prospective cohort study. Aust N Z J Public Health. 2001;25:115-120. (Pubitemid 32451854)
10. Breslow N, Day N. Statistical methods in cancer research Volume2. The design and analysis of cohort studies. Lyon: IARC Press; 1987.
11. McKnight B, Cook LS, Weiss NS. Logistic regression analysis for more than one characteristic of exposure. Am J Epidemiol. 1999;149:984-992. (Pubitemid 29246862)
12. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860-867.
13. Key TJ, Appleby PN, Reeves GK, et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst. 2003;95:1218-1226. (Pubitemid 37069552)
14. Monson RR, Yen S, MacMahon B. Chronic mastitis and carcinoma of the breast. Lancet. 1976;2:224-226.
15. Swedish National Board of Health and Welfare. Breast Feeding, Children Born 2004. Stockholm, Sweden: Hälsa och sjukdomar; 2006:7.
16. Evans M, Heads J. Mastitis: incidence, prevalence and cost. Breastfeed Rev. 1995;3:65-72.
17. Fetherston C. Risk factors for lactation mastitis. J Hum Lact. 1998;14:101-109.
18. Fetherston C. Characteristics of lactation mastitis in a Western Australian cohort. Breastfeed Rev. 1997;5:5-11.
19. Amir LH, Forster DA, Lumley J, McLachlan H. A descriptive study of mastitis in Australian breastfeeding women: incidence and determinants. BMC Public Health. 2007;7:62. (Pubitemid 46761476)
20. Vogel A, Hutchison BL, Mitchell EA. Mastitis in the first year postpartum. Birth. 1999;26:218-225.
21. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50,302 women with breast cancer and 96973 women without the disease. Lancet. 2002;360:187-195. (Pubitemid 34804645)